Literature DB >> 24819499

Operative strategies for patients with failed primary bariatric procedures.

Helena Buhmann1, Larissa Vines, Marc Schiesser.   

Abstract

Bariatric surgery is the most effective therapy to treat obesity and its sequelae. With the increasing incidence of obesity, the number of bariatric procedures has dramatically increased in recent years. The perioperative morbidity reached a very low level, and nearly all revisional bariatric procedures are primarily minimally invasive today. About 10-25% of the patients undergoing bariatric surgery require a revision at some point after their initial operation. Consequently, revisional bariatric surgery has emerged as a distinct practice, performed mainly at tertiary centers, to resolve complications caused by the primary operation and to provide satisfactory weight loss. In this review, our personal experience with revisional bariatric surgery is discussed against the background of the available literature. We further attempt to define major indications for revisional bariatric surgery and balance them with perioperative and long-term morbidity as well as the surgical outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24819499     DOI: 10.1159/000358537

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  3 in total

1.  Conversional Weight Loss Surgery: an Australian Experience of Converting Laparoscopic Adjustable Gastric Bands to Laparoscopic Sleeve Gastrectomy.

Authors:  M Devadas; D J Ku
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

2.  Operative Techniques to Reduce Hip and Knee Arthroplasty Complications in Morbidly Obese Patients.

Authors:  Kelsey A Rankin; David Gibson; Ran Schwarzkopf; Mary I O'Connor; Daniel H Wiznia
Journal:  Arthroplast Today       Date:  2022-08-29

3.  Revisional Gastric Bypass Is Inferior to Primary Gastric Bypass in Terms of Short- and Long-term Outcomes-Systematic Review and Meta-Analysis.

Authors:  Michał Pędziwiatr; Piotr Małczak; Mateusz Wierdak; Mateusz Rubinkiewicz; Magdalena Pisarska; Piotr Major; Michał Wysocki; W Konrad Karcz; Andrzej Budzyński
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.